Membrane Environment Sets the Functional pK a of Ionizable Lipids
Preprint
Abstract
Ionizable aminolipids enable lipid nanoparticles (LNPs) to encapsulate nucleic acids at neutral pH and to release their cargo upon endosomal acidification. The discrepancy between this effective, acidic LNP pK a and the basic intrinsic pK a of aminolipids, however, remains poorly understood. Here, we performed microsecond constant-pH molecular dynamics simulations of five widely used aminolipids (DODAP, DLin-MC3-DMA, DLin-KC2-DMA, ALC-0315, and SM-102) embedded in different LNP-relevant ternary DOPC/D-SPC–cholesterol membranes to quantify how aminolipid structure and membrane composition jointly govern aminolipid protonation and the associated pH-dependent membrane remodeling. Across all systems, membrane embedding lowers the apparent aminolipid pK a , yielding physiologically relevant values of 6–7.5 corresponding to shifts by up to 3.5 pK a units or approx. 20 kJ mol − 1 with respect to the intrinsic pK a . Strikingly, the magnitude of the pK a shift correlates with pH-driven membrane remodeling upon deprotonation: polyunsaturated aminolipids undergo surface-to-core translocation, branched aminolipids preferentially form laterally segregated surface domains, and DODAP remains interfacially anchored through sustained hydration and hydrogen bonding. Saturated helper lipids (DSPC) systematically enhance segregation and amplify pK a shifts relative to DOPC. Together, these results identify membrane phase behavior as a primary regulator of aminolipid protonation equilibria and establish quantitative design principles for tuning LNP composition toward desired pK a , membrane remodeling, and delivery performance.Keywords
This publication has 67 references indexed in Scilit:
- Decoding pH‐Driven Phase Transition of Lipid NanoparticlesSmall, 2026
- Determination of the interior pH of lipid nanoparticles using a pH-sensitive fluorescent dye-based DNA probeBiosensors and Bioelectronics, 2024
- In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacyBiomedicine & Pharmacotherapy, 2023
- mRNA lipid nanoparticle phase transitionBiophysical Journal, 2022
- The role of lipid components in lipid nanoparticles for vaccines and gene therapyAdvanced Drug Delivery Reviews, 2022
- PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM productionInternational Journal of Pharmaceutics, 2020
- Lipid Nanoparticles for Short Interfering RNA Delivery2014
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005